| Stromal modulation and treatment of metastatic pancreatic cancer with local intraperitoneal triple miRNA/siRNA nanotherapy Y Xie, Y Hang, Y Wang, R Sleightholm, DR Prajapati, J Bader, A Yu, ... ACS nano 14 (1), 255-271, 2020 | 137 | 2020 |
| Reversibly stabilized polycation nanoparticles for combination treatment of early-and late-stage metastatic breast cancer G Chen, Y Wang, P Wu, Y Zhou, F Yu, C Zhu, Z Li, Y Hang, K Wang, J Li, ... ACS nano 12 (7), 6620-6636, 2018 | 58 | 2018 |
| Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness Y Xie, Y Wang, J Li, Y Hang, L Jaramillo, CJ Wehrkamp, MA Phillippi, ... Theranostics 8 (16), 4305, 2018 | 43 | 2018 |
| Polyplex-mediated inhibition of chemokine receptor CXCR4 and chromatin-remodeling enzyme NCOA3 impedes pancreatic cancer progression and metastasis Y Wang, S Kumar, S Rachagani, BR Sajja, Y Xie, Y Hang, M Jain, J Li, ... Biomaterials 101, 108-120, 2016 | 39 | 2016 |
| Preferential siRNA delivery to injured kidneys for combination treatment of acute kidney injury W Tang, Y Chen, HS Jang, Y Hang, CM Jogdeo, J Li, L Ding, C Zhang, ... Journal of Controlled Release 341, 300-313, 2022 | 30 | 2022 |
| Polycation fluorination improves intraperitoneal siRNA delivery in metastatic pancreatic cancer Y Hang, S Tang, W Tang, D Větvička, C Zhang, Y Xie, F Yu, A Yu, D Sil, ... Journal of Controlled Release 333, 139-150, 2021 | 27 | 2021 |
| Gene silencing delivery systems for the treatment of pancreatic cancer: Where and what to target next? D Vetvicka, L Sivak, CM Jogdeo, R Kumar, R Khan, Y Hang, D Oupický Journal of Controlled Release 331, 246-259, 2021 | 26 | 2021 |
| Intraperitoneal siRNA nanoparticles for augmentation of gemcitabine efficacy in the treatment of pancreatic cancer S Tang, Y Hang, L Ding, W Tang, A Yu, C Zhang, D Sil, Y Xie, D Oupicky Molecular pharmaceutics 18 (12), 4448-4458, 2021 | 25 | 2021 |
| Promise of chemokine network‐targeted nanoparticles in combination nucleic acid therapies of metastatic cancer Y Xie, Y Wang, J Li, Y Hang, D Oupický Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 11 (2 …, 2019 | 20 | 2019 |
| Use of polymeric CXCR4 inhibitors as siRNA delivery vehicles for the treatment of acute myeloid leukemia Y Wang, Y Xie, J Williams, Y Hang, L Richter, M Becker, C Amador, ... Cancer Gene Therapy 27 (1), 45-55, 2020 | 18 | 2020 |
| Dually active polycation/miRNA nanoparticles for the treatment of fibrosis in alcohol-associated liver disease C Zhang, Y Hang, W Tang, D Sil, HC Jensen-Smith, RG Bennett, ... Pharmaceutics 14 (3), 669, 2022 | 10 | 2022 |
| Synthesis and biological characterization of clicked chloroquine copolymers as macromolecular inhibitors of cancer cell migration F Yu, Y Wang, Y Hang, W Tang, Z Zhao, D Oupický Journal of Polymer Science Part A: Polymer Chemistry 57 (22), 2235-2242, 2019 | 9 | 2019 |
| Hyaluronate-coated perfluoroalkyl polyamine prodrugs as bioactive siRNA delivery systems for the treatment of peritoneal cancers A Yu, S Tang, L Ding, J Foley, W Tang, H Jia, S Panja, CE Holbert, ... Biomaterials advances 136, 212755, 2022 | 8 | 2022 |
| Effect of tocopherol conjugation on polycation-mediated siRNA delivery to orthotopic pancreatic tumors S Tang, E Kapoor, L Ding, A Yu, W Tang, Y Hang, LM Smith, D Sil, ... Biomaterials advances 145, 213236, 2023 | 1 | 2023 |
| THE EFFECT OF AALD ON PHARMACOKINETICS AND BIODISTRIBUTION OF NANOMEDICINES C Zhang, P Wu, Y Hang, T Liner, W Tang, L Ding, RG Bennett, B McVicker, ... The Liver Meeting Digital Experience™, 2020 | | 2020 |
| Development of CXCR4-inhibiting RNA delivery vectors for the treatment of metastatic pancreatic cancer Y Hang | | 2020 |
